The acquisition of the Hitachi S-3400N Type II variable pressure scanning electron microscope with Deben Peltier Coolstage provides a powerful imaging technique to observe and characterize pharmaceutical drug substances and drug products.
WEST LAFAYETTE, Ind., Feb. 3, 2025 /PRNewswire-PRWeb/ -- Scanning electron microscopy is an essential tool in advanced research, manufacturing, and quality control because of its ability to produce high-resolution, three-dimensional images of a material's surface, as well as to analyze its composition at the micro and nano scales. "We use SEMs to examine the morphology, surface texture, and microstructure of materials, all of which are crucial for innovations in pharmaceutical research and design," states Dr. Stephen Byrn, CSO of Improved Pharma. SEMs are an important tool for the inspection of nanostructures, making the technology indispensable for the advancement of nanotechnology.
Improved Pharma and Chemical Microscopy's laboratory recently acquired a Hitachi S-3400N Type II variable pressure scanning electron microscope. SEM analysis allows scientists to optimize drug formulations by characterizing the size, shape, and surface morphology of pharmaceutical drug products. Size distribution within a batch of drug material is often a key quality indicator of a specific product manufacturing processes. A batch with uniform particle size distribution typically ensures uniform dosing and consistent drug release. "SEM analysis plays a critical role in the development of drug-delivery devices by serving as a tool for quality control and failure analysis. The insight and knowledge obtained from direct visualization can be used to optimize manufacturing processes or to assess the uniformity of microstructures," states Dr. Dale K. Purcell, Founder and President of Chemical Microscopy. Microneedles are an example of emerging transdermal drug delivery systems designed to painlessly deliver medications to targeted areas under the skin.
About Chemical Microscopy: Chemical Microscopy is recognized as a world leader in microscopy, microanalysis, microspectroscopy, materials characterization, and the solving of tough pharmaceutical problems using microscopical techniques. The company was founded in 2011.
About Improved Pharma: Improved Pharma is a research and information company dedicated to improving pharmaceutical methods, formulations, and processes. Services include solid-state form studies, formulation design, synchrotron techniques, analytical testing, and expert consulting for the development and defense of intellectual property matters. The company was founded in 2006 by Stephen and Sarah Byrn, who also founded SSCI
Media Contact
Pam Smith, Improved Pharma, (765) 463-9951, [email protected], https://improvedpharma.com/contact/
SOURCE Improved Pharma
Share this article